1. 2017 Workshop on Medroxyprogesterone Acetate (depo-provera®)
Orlando Airport Marriott Lakeside March 13, 2017
Bill Moroney
U.S. Equestrian Chief Executive Officer

2. Agenda Background Workshop Format Introduction of Expert Panel
Introduction of Invited Presenters

3. Background
USEF leadership has not made a decision regarding the use of Depo- Provera®
In conversations with our membership, it became clear that a robust conversation regarding the science and use Depo-Provera® was necessary
Hear the questions and get the answers:
What is the science behind the medication?
Why do people think it is controlling hormone swings that help make horses more manageable?
What is the timing mechanism and how does it work?
Is it a calming agent similar to a tranquilizer that is being used as a training substitute?
Or, does it keep a normal baseline for a horse to function, and is that acceptable?

4. Workshop Format
Workshop information available to those attending in person and watching via live-stream on the Workshop webpage
123 comments and questions were submitted prior to the workshop and will continue to be received until March 20, 2017
Attendees registered online and could request time to present at the Workshop
Invited Presenters will speak first, followed by those attendees that requested time to present
Panelists may ask clarifying questions of the presenters, but will not answer questions during the Workshop. Answers will be provided by April 30.
Following the close of presentations, attendees, USEF staff, Affiliates, and Panel Members may ask additional questions, which will be recorded and evaluated prior to the Panel’s recommendation at the USEF Board of Directors midyear meeting in July

5. Expert panel Geoff Teall
Hunter, Jumper, Equitation Trainer, and Judge with Extensive Career in Equestrian Sport
Dr. Kent Allen, DVM
Chair, USEF Equine Drugs and Medications Committee
Elisabeth Goth
Vice President, USEF Board of Directors; World Champion Saddlebred Breeder and Exhibitor
Laura Graves
Olympic Dressage Medalist

6. Invited Presenters Dr. Jim Heird, Ph.D.
Glenn Blodgett Equine Chair, Executive Professor, and Coordinator Equine Initiative, Texas A&M University
Dr. Stephen Schumacher, DVM
Chief Administrator, USEF Drug and Medications Program
Dr. Patrick McCue, DVM, Ph.D., Diplomat ACT
Professor, Equine Reproduction Laboratory, Colorado State University
Dr. Geoff Vernon, DVM
Equestrian Canada Team Veterinarian, U.S. Team Veterinarian, Member of Equestrian Canada Equine Medication Control Committee
Mary Babick
President, U.S. Hunter Jumper Association
Constance (Sissy) Wickes
Trainer, owner, USEF “R” judge, USHJA Board of Directors

7. Online comments Total Number of Comments Received Online = 110
100,000+ USEF Members
and social media outreach for engagement
All comments were recorded and notes sent to sender
Generally fell into the following topics:
Regumate® substitute and easier to handle
Calms My Horse and I don’t think it tranquilizes them
Don’t ban it for mares
Don’t ban it completely
What’s the Science?

8. Next steps
Video of today’s Workshop will be available on the USEF Network via the Workshop webpage for on-demand viewing
Publications and Research referenced during the Workshop are available on the Workshop’s webpage
Comments may continue to be submitted to until March 20, 2017
After March 20, Panel will review all comments received during the Workshop and online, and will reply to substantive questions by April 30, 2017
By the USEF Board of Directors Mid-Year meeting in July, the Panel will make a recommendation on what actions, if any, to take regarding the use of Depo-Provera®